XM अमेरिका के निवासियों को अपनी सेवाएँ मुहैया नहीं करता है।
S
S

Sonova


समाचार

Amplifon trims margin forecast but rules out competition risk from Apple earbuds

UPDATE 2-Amplifon trims margin forecast but rules out competition risk from Apple earbuds Recasts with detail on competition, adds CEO quote in paragraphs 3,7-8, analyst comment in paragraph 5 By Alberto Chiumento Oct 30 (Reuters) - Italian hearing aid company Amplifon AMPF.MI again trimmed its annual margin guidance on Wednesday, hit by higher marketing costs in Europe in the third quarter, but ruled out competition risks from new players such as Apple AAPL.O .
A
S
A

STOXX 600 rises ahead of key data and US tech earnings, energy shares cap gains

UPDATE 2-STOXX 600 rises ahead of key data and US tech earnings, energy shares cap gains For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Philips tumbles on lowering full-year sales outlook Melrose jumps after risk and revenue sharing explainer Sonova climbs on news of resuming supply to Costco STOXX 600 up 0.4% Updated with closing prices By Ankika Biswas and Pranav Kashyap Oct 28 (Reuters) - Europe's main stock index closed higher on Mo
A
C
E
I
L
M
P
S
W
E
F
S
U
G

Swiss hearing aid maker Sonova resumes supplying Costco, source says

Swiss hearing aid maker Sonova resumes supplying Costco, source says Oct 28 (Reuters) - Swiss hearing aid maker Sonova SOON.S is resuming supplies to Costco COST.O , a source with knowledge of the matter told Reuters on Monday. Its shares rose as much as 7% to their highest in more than two years. The product to be sold at Costco, a prescription hearing aid by the name of Sennheiser Sonite R which was specifically designed for the retailer, will initially be available in 107 locations in the Uni
C
S

Sonova hits over 2-year high after reports it will restart supplies to Costco

BUZZ-Sonova hits over 2-year high after reports it will restart supplies to Costco ** Shares in Swiss hearing aid maker Sonova SOON.S jump 5.2%, trading at their highest levels in over two years, with J.P.Morgan citing reports that it will be back as a supplier for Costco COST.O ** Reports on Friday said Sonova is expected to replace Rexton as a su
C
J
S
S

Airlines lift Europe as oil provides drag

LIVE MARKETS-Airlines lift Europe as oil provides drag Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com AIRLINES LIFT EUROPE AS OIL PROVIDES DRAG The STOXX 600 .STOXX is kicking off the week up 0.4%, buoyed by soaring chemicals and airline stocks, while oil shares drag.
E
L
P
P
S
E
F
U
G

Sonova drops as Barclays downgrades, saying recent launches priced in

BUZZ-Sonova drops as Barclays downgrades, saying recent launches priced in ** Barclays cuts Sonova SOON.S to "equal-weight" from "overweight", saying the Swiss hearing aid group's most recent launches have already been priced in ** Shares in Sonova are down 1.6% ** Barclays says the company's FY guidance is "achievable", but points to limited catal
S
A

BMW, Kingfisher, Spectris

EUROPE RESEARCH ROUNDUP-BMW, Kingfisher, Spectris Sept 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BMW, Kingfisher and Spectris, on Wednesday. HIGHLIGHTS * BMW BMWG.DE : Citigroup raises to neutral from sell * Entain ENT.L : Berenberg raises target price to 1,030p from 1,020p * Kingfisher KGF.L : Citigroup raises target price to 301p from 292p * Spectris SXS.L : HSBC cuts to hold from buy * Whitbread WTB.L : Goldman Sachs cu
A
A
A
B
B
B
C
C
C
D
D
E
E
G
H
I
K
K
S
S
S
W
A
A
A
E
M

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat

Hearing aid makers slip after Apple rolls out hearing aid features, analysts shrug off threat Sept 10 (Reuters) - Shares in European hearing aid makers slipped in early trading on Tuesday after Apple AAPL.O rolled out hearing aid features. Apple said its AirPods Pro 2 could now be "transformed" into a personalized hearing aid via an upcoming software update that would boost specific sounds in real time, including parts of speech or elements within a user's environment.
A
S
A

Banks, energy stocks weigh on European bourses; BMW tumbles

UPDATE 2-Banks, energy stocks weigh on European bourses; BMW tumbles STOXX 600 down 0.5% BMW slumps after cutting profit margin outlook Germany's inflation slowed to 0.2% in August AstraZeneca falls, lung cancer drug trial fails to improve survival Updated at 1615 GMT By Pranav Kashyap and Lisa Pauline Mattackal Sept 10 (Reuters) - European equity markets largely lost ground on Tuesday, weighed by bank and energy stocks as investors tread cautiously ahead of key U.S.
A
A
B
C
C
S
S
A
E
F
U
G

European hearing aid makers slide after Apple rolls out hearing aid features

BUZZ-European hearing aid makers slide after Apple rolls out hearing aid features ** Shares in hearing aid makers slip on Tuesday after Apple AAPL.O rolled out hearing aid features that it has submitted for U.S. regulatory review ** Apple said that its AirPods Pro 2 can be "transformed" into a personalized hearing aid via an upcoming software updat
A
S
A

UBS starts Demant with 'buy', cuts Coloplast to 'sell'

BUZZ-UBS starts Demant with 'buy', cuts Coloplast to 'sell' ** UBS initiates coverage of medical devices maker Demant DEMANT.CO with "buy" rating, and downgrades its Danish peer Coloplast COLOb.CO to "sell" from "neutral" ** It sees Demant to deliver a 13% EPS compound annual growth rate (CAGR) for 2024-2028, ahead of both Swiss rival Sonova SOON.S
S

Accelleron, BHP, Kingfisher

EUROPE RESEARCH ROUNDUP-Accelleron, BHP, Kingfisher Aug 28 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Accelleron, BHP and Kingfisher, on Wednesday. HIGHLIGHTS * Accelleron ACLN.S : Deutsche Bank raises target price to CHF 42 from CHF 34 * BHP Group BHPB.L : JP Morgan cuts target price to 2,580p from 2,650p * Kingfisher KGF.L : Citigroup cuts to neutral from buy * Vonovia SE VNAn.DE : Citigroup raises target price to EUR 52.80 f
A
A
A
B
B
B
C
C
D
E
I
K
N
P
S
S
S
S
T
V
H
B
D

Jefferies says Demant nears valuation trough, ups to 'hold'

BUZZ-Jefferies says Demant nears valuation trough, ups to 'hold' ** Jefferies upgrades Danish hearing aid maker Demant DEMANT.CO to "hold" from "underperform" on low relative valuation, but notes an absence of catalysts for the stock ** It says Demant is nearing a trough in valuation, after Swiss rival Sonova SOON.S outperformed it over the past three months ** Demant's profit warning in July reflects the impact of its brand strategy in the U.S.
S

Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine

BUZZ-Top of the Street: UCB, Moncler, Sonova, Moncler, Voestalpine A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** JP Morgan raises UCB UCB.BR to "overweight" from "neutral" as it sees the Belgian biotech firm's "superior growth profile" as "significantly" undervalued by the market; cites expected acceleration in Bimzelx growth ** Morgan Stanley downgrades Sonova SOON.S to "underweight" from "equal-weight", flagging the hearing aid maker's EV/EBITA valua
M
S
U
V
V

Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova

BUZZ-Morgan Stanley upgrades hearing aid maker Demant, cuts peer Sonova ** Morgan Stanley upgrades hearing aid maker Demant DEMANT.CO to "overweight" from "underweight", while downgrading its peer Sonova SOON.S to "underweight" from "equal-weight" ** Sees an attractive entry point for Demant, citing de-risked estimates after the profit warning and
S

Admiral, UCB SA, Victrex

EUROPE RESEARCH ROUNDUP-Admiral, UCB SA, Victrex Aug 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Admiral, UCB SA and Victrex, on Wednesday. HIGHLIGHTS * Admiral ADML.L : RBC raises target price to 3,550p from 3,400p * Demant A/S DEMANT.CO : Morgan Stanley raises to overweight from underweight * UCB SA UCB.BR : JP Morgan raises to overweight from neutral * Victrex Plc VCTX.L : Jefferies raises to hold from underperform * Watki
A
A
C
H
I
M
N
R
S
S
U
V
V
A



स्थितियाँ

लोकप्रिय परिसंपत्तियाँ

अस्वीकरण: XM Group के सत्व केवल निष्पादन वाली सेवा और हमारी ऑनलाइन व्यापार सुविधा में पहुँच प्रदान करते हैं, ताकि व्यक्ति वेबसाइट पर या उसके जरिए उपलब्ध सामग्री को देख सके और/या उसका उपयोग कर सके। इसका प्रयोजन इसे बदलना या विस्तार देना नहीं है, न ही वह इसे बदलता या विस्तार देता है। इस तरह की पहुँच हमेशा ही निम्नलिखित के अधीन रहेगी: (1) नियम और शर्तें; (2) जोखिम चेतावनियाँ; और (3) पूर्ण अस्वीकरण। इसलिए ऐसी जानकारी सामान्य सूचना से अधिक कुछ भी नहीं है। विशेष रूप से, कृपया इससे अवगत रहें कि हमारी ऑनलाइन व्यापार सुविधा की सामग्रियाँ न तो किसी चीज का अनुरोध करती हैं, न ही वित्तीय बाजारों में प्रवेश करने की पेशकश ही करती हैं। किसी भी वित्तीय बाजार में व्यापार करने के साथ आपकी पूँजी को उल्लेखनीय जोखिम है।

हमारी ऑनलाइन व्यापार सुविधा में प्रकाशित सभी सामग्रियाँ शैक्षणिक/सूचनात्मक प्रयोजनों मात्र के लिए हैं, और इनमें वित्तीय, निवेश टैक्स या व्यापार सलाह और सुझाव नहीं हैं - न ही ऐसा समझना चाहिए कि इनमें ये सब हैं; न ही इनमें हमारी व्यापार कीमतों का अभिलेख है; न ही इनमें किसी वित्तीय उपकरण में लेन-देन करने का निमंत्रण या अनुरोध है; न ही ये आपको अवांछित वित्तयी प्रोमोशन पेश करती हैं।

इस वेबसाइट में मौजूद कोई भी तृतीय पक्षीय सामग्री, तथा XM द्वारा तैयार की गई सामग्रियाँ, जैसे: अभिप्राय, समाचार, अनुसंधान, विश्लेषण, कीमतें और अन्य सूचनाएँ या तृतीय पक्षों की साइटों के लिंक, "जैसा-है-वैसा" के आधार पर बाजार के बारे में सामान्य टिप्पणी के रूप में उपलब्ध कराई गई हैं, और वे निवेश हेतु सलाह नहीं हैं। जिस हद तक कीसी सामग्री को निवेश अनुसंधान मान लिया जाता है, उस हद तक आपको ध्यान में रखना होगा और इसे स्वीकार करना होगा कि वह सामग्री इस उद्देश्य से और निवेश अनुसंधान की स्वतंत्रता को बढ़ावा देने के लिए कानूनी आवश्यकताओं के मुताबिक, तैयार नहीं की गई है, और इसलिए उसे प्रासंगिक कानूनों और विनियमों के तहत विपणन संप्रेषण माना जाएगा। कृपया सुनिश्चित करें कि आपने गैर-आश्रित निवेश के बारे में हमारी सूचना को पढ़ और समझ लिया है। पीछे दी गई जानकारी के बारे में अनुसंधान और जोखिम चेतावनी यहाँ उपलब्ध है।

जोखिम की चेतावनी: आपकी पूँजी जोखिम में है। लीवरेज वाले उत्पाद सबके उपयुक्त नहीं होते हैं। कृपया हमारे जोखिम खुलासे पर विचार करें।